Related references
Note: Only part of the references are listed.Silica-based nanomaterials as drug delivery tools for skin cancer (melanoma) treatment
Hoang Trung Trinh et al.
EMERGENT MATERIALS (2021)
Fucosylated lipid nanocarriers loaded with antibiotics efficiently inhibit mycobacterial propagation in human myeloid cells
Veronica Duran et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Formulation and Intracellular Trafficking of Lipid-Drug Conjugate Nanoparticles Containing a Hydrophilic Antitubercular Drug for Improved Intracellular Delivery to Human Macrophages
Sayantan Pandit et al.
ACS OMEGA (2020)
Drug-Resistant Tuberculosis 2020: Where We Stand
Angelo Iacobino et al.
APPLIED SCIENCES-BASEL (2020)
Polymersomes Eradicating Intracellular Bacteria
Federico Fenaroli et al.
ACS NANO (2020)
Mycobacterium Lipids Modulate Host Cell Membrane Mechanics, Lipid Diffusivity, and Cytoskeleton in a Virulence-Selective Manner
Manjari Mishra et al.
ACS INFECTIOUS DISEASES (2020)
Heterogeneity in the endocytic capacity of individual macrophage in a population determines its subsequent phagocytosis, infectivity and subcellular trafficking
Kuldeep Sachdeva et al.
TRAFFIC (2020)
In vitro and in vivo antitubercular activity of benzothiazinone-loaded human serum albumin nanocarriers designed for inhalation
Ayasha Patel et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Engineering PLGA-Lipid Hybrid Microparticles for Enhanced Macrophage Uptake
Sajedeh Maghrebi et al.
ACS APPLIED BIO MATERIALS (2020)
Recent advances in stimuli-responsive drug release and targeting concepts using mesoporous silica nanoparticles
Ghada G. Abdo et al.
EMERGENT MATERIALS (2020)
WHO global progress report on tuberculosis elimination (vol 8, pg 19, 2020)
E. Harding
LANCET RESPIRATORY MEDICINE (2020)
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation
Kinam Park et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Preferential uptake of chitosan-coated PLGA nanoparticles by primary human antigen presenting cells
Veronica Duran et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo
Alissa C. Rothchild et al.
SCIENCE IMMUNOLOGY (2019)
Dynamic Remodeling of the Host Cell Membrane by Virulent Mycobacterial Sulfoglycolipid-1
Manjari Mishra et al.
SCIENTIFIC REPORTS (2019)
Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages
Ana Costa et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Ex vivo expansion of alveolar macrophages with Mycobacterium tuberculosis from the resected lungs of patients with pulmonary tuberculosis
Elena Ufimtseva et al.
PLOS ONE (2018)
Enhanced Permeability and Retention-like Extravasation of Nanoparticles from the Vasculature into Tuberculosis Granulomas in Zebrafish and Mouse Models
Federico Fenaroli et al.
ACS NANO (2018)
High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types
Landry Blanc et al.
ELIFE (2018)
Food-grade cationic antimicrobial ε-polylysine transiently alters the gut microbial community and predicted metagenome function in CD-1 mice
Xiaomeng You et al.
NPJ SCIENCE OF FOOD (2017)
Size-dependent deposition of inhaled nanoparticles in the rat respiratory tract using a new nose-only exposure system
Alison Buckley et al.
AEROSOL SCIENCE AND TECHNOLOGY (2016)
Dry powder inhalable formulations for anti-tubercular therapy
Thaigarajan Parumasivam et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
A novel and simple preparative method for uniform-sized PLGA microspheres: Preliminary application in antitubercular drug delivery
Zhiqiang Liu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
TB deaths rank alongside HIV deaths as top infectious killer
Philippe Glaziou et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin
Rohan V. Pai et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2016)
Tuberculosis
Madhukar Pai et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages
Wing-Hin Lee et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Mycolic acids, a promising mycobacterial ligand for targeting of nanoencapsulated drugs in tuberculosis
Yolandy Lemmer et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs
Lucila Garcia Contreras et al.
MOLECULAR PHARMACEUTICS (2015)
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux et al.
NATURE MEDICINE (2015)
Rifampicin Loaded Mannosylated Cationic Nanostructured Lipid Carriers for Alveolar Macrophage-specific Delivery
Xu Song et al.
PHARMACEUTICAL RESEARCH (2015)
Delivery of antibiotics with polymeric particles
Meng-Hua Xiong et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Surface charge of PLA microparticles in regulation of antigen loading, macrophage phagocytosis and activation, and immune effects in vitro
Yuying Liu et al.
PARTICUOLOGY (2014)
Physicochemical Properties Determine Nanomaterial Cellular Uptake, Transport, and Fate
Motao Zhu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2013)
Distribution and deposition of respirable PLGA microspheres in lung alveoli
Keiji Hirota et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition
Rachit Agarwal et al.
THERAPEUTIC DELIVERY (2013)
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Alexandre Albanese et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 14 (2012)
Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles
Daniel L. Clemens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Partial Biodistribution and Pharmacokinetics of Isoniazid and Rifabutin Following Pulmonary Delivery of Inhalable Microparticles to Rhesus Macaques
Rahul Kumar Verma et al.
MOLECULAR PHARMACEUTICS (2012)
High-Sensitivity MALDI-MRM-MS Imaging of Moxifloxacin Distribution in Tuberculosis-Infected Rabbit Lungs and Granulomatous Lesions
Brendan Prideaux et al.
ANALYTICAL CHEMISTRY (2011)
The Application of High-Content Analysis in the Study of Targeted Particulate Delivery Systems for Intracellular Drug Delivery to Alveolar Macrophages
Ciaran Lawlor et al.
MOLECULAR PHARMACEUTICS (2011)
The devil's advocacy: When and why inhaled therapies for tuberculosis may not work
Awadh Bihari Yadav et al.
TUBERCULOSIS (2011)
Inhaled drug therapy for treatment of tuberculosis
Amit Misra et al.
TUBERCULOSIS (2011)
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
Chunbai He et al.
BIOMATERIALS (2010)
One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis
Katsuya Ohashi et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery
Jean C. Sung et al.
PHARMACEUTICAL RESEARCH (2009)
Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice
Rahul Kumar Verma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats
Wassana Wijagkanalan et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Stimulation of phagocytic activity of alveolar macrophages toward artificial microspheres by infection with mycobacteria
Keiji Hirota et al.
PHARMACEUTICAL RESEARCH (2008)
Role of particle size in phagocytosis of polymeric microspheres
Julie A. Champion et al.
PHARMACEUTICAL RESEARCH (2008)
Inhalable microparticles containing large payload of anti-tuberculosis drugs
Pavan Muttil et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages
Keiji Hirota et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Anti-infectives - Adverse reactions to first-line antituberculosis drugs
Eric J. Forget et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
NR Labiris et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Share Paper
